Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array
Open Access
- 22 June 1999
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (13), 7382-7387
- https://doi.org/10.1073/pnas.96.13.7382
Abstract
The p53 gene was sequenced in 100 primary human lung cancers by using direct dideoxynucleotide cycle sequencing and compared with sequence analysis by using the p53 GeneChip assay. Differences in sequence analysis between the two techniques were further evaluated to determine the accuracy and limitations of each method. p53 mutations were either detected by using both techniques or, if only detected by one technique, were confirmed by using mutation-specific oligonucleotide hybridization. Dideoxynucleotide sequencing of the conserved regions of the p53 gene (exons 5–9) detected 76% of the mutations within this region of the gene. The GeneChip p53 assay detected 81% of all (exons 2–11) mutations, including 80% of the mutations within the conserved regions of the gene. The GeneChip assay detected 46 of 52 missense mutations (88%), but 0 of 5 frameshift mutations. The specificity of direct sequencing and of the p53 GeneChip assay at detecting p53 mutations were 100% and 98%, respectively. The GeneChip p53 assay is a rapid and reasonably accurate approach for detecting p53 mutations; however, neither direct sequencing nor the p53 GeneChip are infallible at p53 mutation detection.Keywords
This publication has 23 references indexed in Scilit:
- Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysisNature Genetics, 1996
- CLINICAL IMPLICATIONS OF THE p53 GENEAnnual Review of Medicine, 1996
- p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survivalAnnals of Oncology, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Prognostic value and clinicopathologic correlation of p53 gene mutations and nuclear DNA content in human lung cancer: A prospective studyJournal of Surgical Oncology, 1994
- Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Identification of p53 Gene Mutations in Bladder Cancers and Urine SamplesScience, 1991
- Light-Directed, Spatially Addressable Parallel Chemical SynthesisScience, 1991
- Fluorescence detection in automated DNA sequence analysisNature, 1986